Sophisticated purchasing of pharmaceuticals: learning from other countries

28 September 2020 - In 2019 and early 2020, drug pricing in the United States was a top concern of ...

Read more →

Heron Therapeutics receives European Commission authorisation for Zynrelef (HTX-011) for the treatment of post-operative pain

28 September 2020 - Heron Therapeutics today announced that the European Commission has granted a marketing authorisation for Zynrelef (formerly known ...

Read more →

Election campaign 2020: Jacinda Ardern unveils $1 billion health policy

29 September 2020 - Labour is promising to invest millions more in drug-buying agency PHARMAC and emergency dental care if ...

Read more →

Shionogi announces FDA approval of Fetroja (cefiderocol) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

29 September 2020 - Shionogi today announces that the U.S. FDA has approved a supplemental new drug application for Fetroja ...

Read more →

U.S. FDA approves Pfizer's Xeljanz (tofacitinib) for the treatment of active polyarticular course juvenile idiopathic arthritis

28 September 2020 - Pfizer announced today that the U.S. FDA approved Xeljanz (tofacitinib) for the treatment of children and adolescents ...

Read more →

Orchard Therapeutics receives EMA PRIME designation for OTL-203 for the treatment of MPS-I

28 September 2020 - Orchard Therapeutics today announced that the EMA has granted Priority Medicines (PRIME) designation to OTL-203, an investigational ...

Read more →

Maritime union rejects claims medical supplies and food are being held up in pay dispute

29 September 2020 - There are fears container ships stuck off the Sydney coast could result in major delays to ...

Read more →

Worst-rank score methods—a non-parametric approach to informatively missing data

28 September 2020 - A previous JAMA Guide to Statistics and Methods article briefly reviewed non-parametric statistics.  ...

Read more →

ISPOR introduces new competencies framework for health economics and outcomes research professionals

28 September 2020 - Important step in establishing agreement on the knowledge, skills and attributes required in HEOR. ...

Read more →

U.S. FDA approves Haegarda (C1 esterase inhibitor subcutaneous [human]) for prevention of hereditary angioedema attacks in paediatric patients

28 September 2020 - Haegarda is the first and only subcutaneous prophylactic hereditary angioedema treatment approved for children 6 years of ...

Read more →

AbbVie receives orphan drug and fast track designations from the U.S. FDA for elezanumab, an investigational monoclonal antibody RGMa inhibitor, for the treatment of spinal cord injury

28 September 2020 - Elezanumab (ABT-555) is an investigational treatment being evaluated in neurological disorders, including treatment following spinal cord injury. ...

Read more →

ICER publishes white paper on cornerstones for fair patient access to prescription drugs, launches annual assessment of US payer policies

28 September 2020 - Informed by expert input from patient groups, clinician specialty societies, payers, and life science companies, white paper ...

Read more →

Khondrion receives rare paediatric disease designation for sonlicromanol from US FDA

28 September 2020 - Designation granted for the treatment of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome. ...

Read more →

Ultomiris (ravulizumab) receives approval in Japan for atypical haemolytic uraemic syndrome in adults and children

25 September 2020 - Ultomiris is the first and only long-acting C5 inhibitor for atypical haemolytic uraemic syndrome, reducing the treatment ...

Read more →

Enhertu approved in Japan for the treatment of patients with HER2 positive metastatic gastric cancer

25 September 2020 - Approval of SAKIGAKE designated medicine is based on pivotal phase 2 DESTINY-Gastric01 trial and represents second approval ...

Read more →